ZetrOZ Systems is set to attend the annual meeting of the Society of Military Orthopaedic Surgeons (SOMOS 2023) to showcase its sam® wearable ultrasound unit and demonstrate its proven ability to speed up soft tissue healing pre- and post-surgery. The sam® device is a new treatment option that is covered by insurance for active-duty military and veterans through government healthcare plans, reducing the need for surgery and the use of opioids while helping the body to actively heal daily.
SOMOS’s conference is the leading event for military and orthopaedic trauma surgeons, orthopaedic specialists, and healthcare professionals in related fields who want to stay ahead in the field of medicine. The event will be held from December 4-6 at The Hythe Resort in Vail, Colorado. ZetrOZ Systems will be showcasing its latest treatment technology at Booth 54.
ZetrOZ Systems is the creator of sustained acoustic medicine and the manufacturer of the sam® 2.0 and sam® X1 soft tissue healing devices. These are the only ultrasound technologies cleared by the U.S. Food and Drug Administration for daily home use. The effectiveness of ZetrOZ’s technology and the sam® devices in treating soft tissue and other injuries has been documented in 42 peer-reviewed publications and 20 Level 1-5 clinical studies.
“Research overwhelmingly shows that sustained acoustic medicine can be a valuable aspect of the spectrum of therapies that orthopedic surgeons provide,” said Dr. George Lewis, founder and CEO of ZetrOZ Systems. “We’re particularly grateful for this opportunity to demonstrate our technology to the physicians who care for members of our military, whose service to our country often puts them in situations where they are vulnerable to the soft tissue injuries that our sam® devices are designed to treat.”
One major study, titled “Evaluation of Sustained Acoustic Medicine for Treating Musculoskeletal Injuries in Military and Sports Medicine” and published in Open Orthopedics Journal in December 2022, reported the findings of 239 experienced college and military healthcare providers who used sustained acoustic medicine to promote soft tissue healing.
An overwhelming majority of medical professionals (83%) found that sustained acoustic medicine, in combination with topical medication, provided “excellent” or “good” benefits to their patients, while 11% found it added some benefits.
Most medical professionals said that sustained acoustic medicine provided clinical improvement in under two weeks (68.9% of responses) and that sustained acoustic medicine allowed a 50% reduction in pain medication (63%). “SAM (Sustained Acoustic Medicine) is an effective, safe, easy-to-use, noninvasive, comfortable, and versatile therapeutic for healing musculoskeletal injuries,” the researchers concluded.
A recent study published in 2020 in the Journal of Orthopaedic Surgery and Research reviewed various research on the use of sustained acoustic medicine in treating knee osteoarthritis. According to the researchers, SAM, when combined with physical therapy, provides better outcomes for patients without the use of drugs or injections. It also provides significant cost savings for the treatment of a lifelong progressing disease. ZetrOZ developed this technology with funding from the National Institute of Health, National Science Foundation, Department of Defense, and NASA, and it is currently protected by 46 U.S. patents.
